Celularity (CELU) Payables (2018 - 2025)
Celularity (CELU) posted quarterly Payables of $26.5 million for Q4 2025, up 2.84% year-over-year from $25.8 million in Q4 2024, and down 8.16% quarter-over-quarter from $28.9 million in Q3 2025.
Celularity (CELU) Payables (2018 - 2025) Analysis & Trends
Celularity (CELU) has reported Payables for 8 consecutive years, with $26.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables rose 2.84% year-over-year to $26.5 million; the TTM figure through Dec 2025 stood at $26.5 million (up 2.84% YoY), while the FY2025 annual figure was $26.5 million, up 2.84% from the prior year.
- Payables slipped to $26.5 million in Q4 2025 per CELU's latest filing, from $28.9 million in the prior quarter.
- Across five years, Payables topped out at $48.5 million in Q3 2022 and bottomed at $5.2 million in Q1 2021.
- Historically, Payables has averaged $22.4 million across 5 years, with a median of $26.1 million in 2024.
- Annual changes were most pronounced in 2021 — Payables soared 14989.52% — and 2024, when it tumbled 67.3%.
- Celularity's Payables stood at $9.3 million in 2021, then soared by 365.95% to $43.4 million in 2022, then decreased by 27.75% to $31.4 million in 2023, then slipped by 17.81% to $25.8 million in 2024, then advanced by 2.84% to $26.5 million in 2025.
- Business Quant data shows CELU's Payables at $26.5 million in Q4 2025, $28.9 million in Q3 2025, and $28.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | 26.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.51 Mn |
| Sep 30, 2025 | 28.87 Mn |
| Jun 30, 2025 | 28.70 Mn |
| Mar 31, 2025 | 27.47 Mn |
| Dec 31, 2024 | 25.78 Mn |
| Sep 30, 2024 | 15.40 Mn |
| Jun 30, 2024 | 13.73 Mn |
| Mar 31, 2024 | 12.98 Mn |
| Dec 31, 2023 | 31.37 Mn |
| Sep 30, 2023 | 26.94 Mn |
| Jun 30, 2023 | 29.26 Mn |
| Mar 31, 2023 | 39.70 Mn |
| Dec 31, 2022 | 43.41 Mn |
| Sep 30, 2022 | 48.47 Mn |
| Jun 30, 2022 | 10.23 Mn |
| Mar 31, 2022 | 10.42 Mn |
| Dec 31, 2021 | 9.32 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 7.29 Mn |
| Mar 31, 2021 | 5.16 Mn |